New Technologies for Disinfection of Environmental Surfaces John M. - - PowerPoint PPT Presentation

new technologies for disinfection of environmental
SMART_READER_LITE
LIVE PREVIEW

New Technologies for Disinfection of Environmental Surfaces John M. - - PowerPoint PPT Presentation

New Technologies for Disinfection of Environmental Surfaces John M. Boyce, MD J.M. Boyce Consulting, LLC Middletown, CT Disclosures: JMB is a consultant to, and has received travel support from, Diversey and GOJO Industries, and has received


slide-1
SLIDE 1

New Technologies for Disinfection

  • f Environmental Surfaces

John M. Boyce, MD J.M. Boyce Consulting, LLC Middletown, CT

www.jmboyceconsulting.com

Disclosures: JMB is a consultant to, and has received travel support from, Diversey and GOJO Industries, and has received an honorarium from Sodexo

slide-2
SLIDE 2

Burden of Healthcare-Associated Infections Due to Antimicrobial-Resistant Organisms

  • 10% to 15% of all hospital patients and 65% of all nursing

home residents are colonized with one or more multidrug- resistant organisms (MDROs)

  • Antibiotic-resistant organisms are responsible for:
  • More than 2 million healthcare-associated infections

(HAIs), and 23,000 deaths per year in the United States

  • At a direct cost of $20 billion
  • More than 220,000 HAIs occur in Canada annually and

result in 8,500 - 12,000 deaths

Manning ML et al. Am J Infect Control 2018;46:364

slide-3
SLIDE 3

Role of Environment in Transmission of Healthcare-Associated Pathogens

  • Increasing evidence that contaminated environmental surfaces

contribute to transmission of healthcare-associated pathogens

  • Contaminated surfaces serve as a source of:
  • Contamination of the hands of healthcare personnel (HCP)
  • Transmission to patients via direct contact
  • There is substantial evidence that improving environmental

disinfection reduces transmission of pathogens

  • Novel strategies for improving daily and terminal disinfection of

environmental surfaces warrant further evaluation

Hayden MK et al. Infect Control Hosp Epidemiol 2008;29:149 Otter JA et al. Infect Control Hosp Epidemiol 2011;32:687 Weber DJ et al. Curr Opin Infect Dis 2013;26:338 Donskey CJ Am J Infect Control 2013;41:S12 Boyce JM Antimicrob Resist Infect Control 2016; doi 10.1186/s13756-016-0111-x PIDAC Best Practices for Environmental Cleaning, 2018

slide-4
SLIDE 4

Daily Cleaning/Disinfection Practices Are Often Suboptimal

  • Patients colonized or infected with

pathogens shed the organisms onto environmental surfaces

  • Daily cleaning of surfaces by

Environmental Services (EVS) staff can vary considerably, and is sometimes suboptimal

  • Poor daily disinfection practices or use
  • f an ineffective agent results in

persistent contamination of surfaces

Overbed Table Overbed Table Before Cleaning After Cleaning VRE on call button after cleaning

Hayden MK et al. Clin Infect Dis 2006;42:1552 Eckstein BC et al. BMC Infect Dis 2007;7:61 Faires MC et al. BMC Infect Dis 2012;12:290 Boyce JM et al. Infect Control Hosp Epidemiol 2010;31:99 Gavalda L et al. Am J Infect Control 2015;43:776

slide-5
SLIDE 5

Importance of Daily Room Cleaning and Disinfection

  • Appropriate daily cleaning reduces:
  • Level of environmental contamination by pathogens
  • Transfer of pathogens from surfaces to hands of healthcare personnel

(HCP)

  • Acquisition of pathogens by patients
  • HAIs

5

Hayden MK et al. Clin Infect Dis 2006;42:1552 Hardy KJ et al. J Hosp Infect 2007;66:360 Meakin NS et al. J Hosp Infect 2012;80:122 Eckstein BC et al. BMC Infect Dis 2007;7:61 Kundrapu S et al. Infect Control Hosp Epidemiol 2012;33:1039 Donskey CJ Am J Infect Control 2013;41:S12 Boyce JM et al. Am J Infect Control 2017;45:1006

slide-6
SLIDE 6

Need for Innovative Approaches to Daily Disinfection of Surfaces

  • High-touch surfaces become re-contaminated with pathogens

within hours after daily cleaning

  • Cleaning high-touch surfaces more than once/day can reduce

both microbial burden on surfaces and HAIs

  • Novel approaches for disinfecting patient rooms more

frequently than once/day are needed

Hardy KJ et al. J Hosp Infect 2007;66:360 Aldeyab MA et al. Infect Control Hosp Epidemiol 2009;30:304 Wilson AP et al. Crit Care Med 2011; Attaway HH et al. Am J Infect Control 2012;40:907 Bogusz A et al. Healthcare Infect 2013;18:3 Schmidt MG et al. Infect Control Hosp Epidemiol 2013;34:530 Dancer SJ et al. BMC Med 2009;7:28

slide-7
SLIDE 7

Importance of Terminal Room Cleaning/Disinfection

  • Multiple studies have assessed terminal room disinfection by
  • btaining cultures Before and After terminal room

cleaning/disinfection

  • Quality of both daily and terminal cleaning is highly variable, and is
  • ften suboptimal
  • Residual contamination of surfaces occurs if terminal disinfection is

not performed correctly

7

Otter JA et al. J Hosp Infect 2007;67:182 Hota B et al. J Hosp Infect 2009;71:123 Otter JA et al. Am J Infect Control 2010;38:754 Carling PC et al. Infect Control Hosp Epidemiol 2008;29:1035 Boyce JM et al. Infect Control Hosp Epidemiol 2011;32:1187 Manian FA Am J Infect Control 2013;41:384 Sitzlar B et al. Infect Control Hosp Epidemiol 2013;34:459 Rupp ME et al. Infect Control Hosp Epidemiol 2014;35:721 Ali S et al. J Hosp Infect 2016;93:70

slide-8
SLIDE 8

Level of MDRO Surfaces Contamination After Manual Terminal Cleaning, BETR study

N = 80 CFU (~ 3 CFU/cm2)

Chen LF et al. Infect Control Hosp Epidemiol 2019;40:47

Baseline Contamination of Hospital Surfaces at Enrollment by Pathogen

  • Prospective study of surface contamination

and MDRO transmission events

  • Rooms vacated by patients on Contact Precautions

cultured when new patients were admitted

  • > 1 MDRO was recovered from 55% of rooms

after manual terminal cleaning

slide-9
SLIDE 9

Risk Associated with Prior Room Occupancy

  • Patients admitted to a

room previously

  • ccupied by a patient

with a resistant pathogen are at increased risk of acquiring the organism

  • On average, they are

twice as likely to acquire the pathogen as patients admitted to a room not

  • ccupied by a patient

with a resistant pathogen

Risk of Acquisition of pathogens from Prior Room Occupants

Mitchell DB et al. J Hosp Infect 2015;91:211

slide-10
SLIDE 10

Rationale for Adopting New Technologies to Supplement Manual Disinfection Practices

  • Continuing challenges affecting effectiveness of

environmental disinfection programs:

  • Frequent personnel turnover in EVS departments
  • Low salaries available for EVS personnel
  • Inadequate training of EVS and nursing personnel
  • Confusion among EVS and nursing personnel regarding “who is

supposed to clean what?”

  • New strategies for cleaning/disinfecting environmental

surfaces are needed

  • “No-touch” methods designed to supplement manual

disinfection are gaining popularity, but choosing the most appropriate technology can be difficult

Zuberi DM et al. Soc Sci Med 2011;72:907 Dumigan DG et al. Am J Infect Control 2010;38:387 Anderson RE et al. J Hosp Infect 2011;78:178

slide-11
SLIDE 11

No-Touch Disinfection Technologies

  • Hydrogen peroxide vapor (HPV)
  • Aerosolized hydrogen peroxide
  • HPV + peracetic acid
  • Ozone gas
  • Quaternary ammonium fogging
  • Alcohol mist
  • Steam vapor
  • Aerosolized peracetic acid/H2O2
  • Ultraviolet light
  • Mobile devices
  • Fixed installations
  • Self-disinfecting surfaces
  • Copper alloys
  • Silver
  • Organosilane surface applications
  • High- intensity, narrow spectrum

light (405 nm)

  • UV-based air disinfection systems

Doll M et al. Curr Infect Dis Rep 2015;17:44 Weber DJ et al. Am J Infect Control 2016;44(5 Suppl):e77 Weber DJ et al. Curr Opin Infect Dis 2016;29:424 Marra AR et al. Infect Control Hosp Epidemiol 2018;39:20 PIDAC Best Practices for Environmental Cleaning, 3rd ed., 2018

slide-12
SLIDE 12

Hydrogen Peroxide Vapor Micro-Condensation Process

  • Hydrogen peroxide vapor (HPV) micro-condensation

process

  • Uses 30% - 35% H2O2
  • Produces vapor [gas] (particle size < 1 u)
  • H2O2 is distributed throughout room being treated
  • H2O2 converted to water and oxygen (no residue)
  • Effective against a broad range of healthcare-

associated pathogens including C. difficile spores

  • Yields 105 to 106 log10 reduction of most pathogens
  • Air ducts and doors must be closed during process,

which takes 2-3 hours

Generator Aeration unit Otter JA et al. J Hosp Infect 2011;83:1 Weber DJ et al. Am J Infect Control 2016;44(5 Suppl):e77 Marra AR et al. Infect Control Hosp Epidemiol 2018;39:20 PIDAC Best Practices for Environmental Cleaning, 2018

slide-13
SLIDE 13

Hydrogen Peroxide Vapor

  • Multiple studies have shown that HPV reduces bacterial

contamination of surfaces in outbreak and non-outbreak settings

  • Impact of HPV on MDRO acquisition or infection
  • 5 studies in outbreak settings
  • 4 studies in non-outbreak settings
  • All studies showed reduction of HAIs due to target pathogens
  • Regression to the mean may have explained some reductions
  • Due to room turn-around times, HPV is not practical for

routine terminal room disinfection

  • Most likely to be helpful for:
  • Terminating outbreaks or transmission in hyperendemic settings
  • Reducing difficult-to-eradicate or highly dangerous pathogens

Weber DJ et al. Am J Infect Control 2016;44(5 Suppl):e77 Marra AR et al. Infect Control Hosp Epidemiol 2018;39:20 PIDAC Best Practices for Environmental Cleaning, 2018

slide-14
SLIDE 14

Hydrogen Peroxide “Dry” Mist Systems

  • One system uses 5% H2O2, <50 ppm silver and <50 ppm
  • rthophosporic acid
  • Inactivated < 10% of pouched 106 G. stearothermophilus spores

(BIs)

  • ~33% of 104 G. stearothermophilus spores
  • Uneven distribution within room
  • Has shown reduction in bacterial contamination in experimental

and actual hospital rooms

  • Eliminated growth of bacteria and mold from surfaces in 5 rooms
  • f a burn unit
  • Clinical isolates and reference strains inoculated on glass carriers

3 – 4.6 log10 reductions of various pathogens were achieved

  • Less effective than HPV vs C. difficile spores

Andersen BM et al. J Hosp Infect 2006;62:149 Bartels MD et al. J Hosp Infect 2008;70:35 Shapey S et al. J Hosp Infect 2008;70:136 Fu TY et al. J Hosp Infect 2012:80:199 Cobrado L et al. Surg Infect 2018;19: doi 10.1089/sur.2017.311 Herruzo R J Hosp Infect 2014;87:175

slide-15
SLIDE 15

Hydrogen Peroxide “Dry” Mist Systems

  • Another system uses 6% - 12 % H2O2 and creates a fog
  • One study compared the system to detergent cleaner
  • Percent of rooms yielding MRSA after use of detergent

vs H2O2 was 24.7% vs 18.8% (p < .001)

  • Significant reduction occurred at only one site (bed)
  • Significant reduction in MRSA acquisition and infection
  • Multiple confounding variables were present
  • Another study found only ~1.0 – 1.7 log10 reductions of

VRE

  • No convincing data regarding impact on HAIs for

either “dry mist” system

Mitchell BG et al. BMJ Open 2014;4:e004522 Chan HT et al. J Hosp Infect 2011;79:125

slide-16
SLIDE 16

UVC Light Room Decontamination Systems

  • Automated mobile UV light units that emit UVC (254 nm range) are available

in a variety of sizes, designs and acquisition & maintenance costs

  • Some units have built-in sensors; some provide separate sensors
  • Some have software for tracking usage
slide-17
SLIDE 17

1,00E-05 1,00E-04 1,00E-03 4 ft Direct 4 ft Zero Angle 10 ft Direct 10 ft Zero Angle Shaded 4 ft Shaded 10 ft

Mean UVC Irradiance (W/cm2)

Cadnum JL et al. Infect Control Hosp Epidemiol 2016;37:555 Boyce JM et al. Infect Control Hosp Epidemiol 2016;37:667

Parameters Effecting UVC Effectiveness

  • UV-C irradiance and antimicrobial efficacy are effected by test methods
  • Method of preparing inoculum of test pathogens
  • Area over which the inoculum is spread on test surfaces
  • Distance and orientation of test surfaces relative to the UVC device
  • Types of organic load used in tests
slide-18
SLIDE 18

Impact of Distance from UVC Device and Angle of UV Light on Log10 Reductions Achieved

0,5 1 1,5 2 2,5 3 3,5 4 4,5 5

1.3 m, direct 1.3 m, 0 °angle 1.3 m, shaded 3.3 m, direct 3.3 m, 0° angle 3.3 m, shaded

Mean Log10 Reduction MRSA

  • C. difficile

Data source: Boyce JM et al. Infect Control Hosp Epidemiol 2016;37:667-672

slide-19
SLIDE 19

Comparison of Two UVC Devices

  • Devices were tested for log10 reductions

against

  • MRSA, C. difficile, VRE
  • Results:
  • Both devices yielded similar reductions at

4 ft from devices with 41-min cycles

  • VRE - 5 log10 reductions
  • MRSA - 4 log10 reductions
  • C. difficile - ~ 3 log10 reductions
  • Efficacy was decreased with
  • Presence of organic load
  • Increasing distance from device
  • Location in shaded area (indirect light)
  • UVC dose delivered

Nerandzic MM PLoS One 2014;9:e107444

slide-20
SLIDE 20

Comparison of two UVC Devices

  • Efficacy of 2 UVC devices were compared
  • 360 surfaces in rooms of patients with MRSA, VRE or C. difficile
  • Stainless steel carrier inoculated with MRSA and VRE
  • Percent of surfaces contaminated
  • After manual cleaning:
  • MRSA – 27.9%, VRE – 29.5%, C. difficile – 22.7%
  • After UVC disinfection
  • MRSA – 3.3%, VRE – 4.9%, C. difficile – 0%
  • Odds of detecting growth on carriers was 7 times higher for

1 machine for a given organism, surface and concentration

  • Conclusions:
  • UVC devices are effective, but vary in the ability to reduce high

concentrations of organisms in the presence of organic material

  • Set-up times and cycle times vary considerably; may affect choice

Wong T et al. Am J Infect Control 2016;44:416

slide-21
SLIDE 21

Comparison of UVC and Pulsed Xenon Devices

  • A study compared UVC and pulsed xenon (PX-UV) devices

effectiveness against C. difficile, MRSA and VRE

  • 10-min cycles were run, with slides at 4 ft from device
  • Impact of distance from device, organic load and indirect light were

evaluated

  • Outcomes:
  • Reduction of pathogens on glass slides
  • Reduction of bacteria on hospital surfaces
  • Results:
  • Log10 reductions on glass slides achieved with PX-UV

VRE – 0.6; MRSA – 1.85; C. difficile – 0.55

  • Efficacy of PX-UV was dramatically reduced by increasing distance,

but not by organic load or indirect light

Nerandzic MM et al. Infect Control Hosp Epidemiol 2015;36:192

slide-22
SLIDE 22

Comparison of UVC and Pulsed Xenon Devices

  • Log10 reductions

achieved by UVC device were significantly greater than PX-UV for all 3 pathogens

  • PX-UV reduced bacteria
  • n clinical surfaces

Nerandzic MM et al. Infect Control Hosp Epidemiol 2015;36:192

slide-23
SLIDE 23

Comparison of UV devices in Radiology Procedure Room

  • Prospective study of 8 mobile UV

devices in Radiology Dept.

  • 4 standard vertical towers (LPM 1-4)
  • 1 pulsed xenon device
  • 1 with adjustable bulbs
  • Fixed position and robotic
  • 1 with 3 vertical towers
  • UV irradiance measured
  • Reduction of pathogens on

stainless steel disks measured

  • 4-minute cycle time used
  • UV-C devices emitted 254 nm light;

different levels of irradiance (intensity)

  • Pulsed xenon device emitted

mostly UV-A and UV-B

  • Very little UVC (254 nm)

Cadnum JL et al. Infect Control Hosp Epidemiol 2019;40:158

Standard tower units Non-standard UV-C units

slide-24
SLIDE 24

Comparison of UV devices in Radiology Procedure Room

  • All UVC devices reduced pathogens on disks significantly

more than the pulsed xenon device (p < .0001 for all)

  • Efficacy of 4 standard UVC devices (LPM 1-4) was similar
  • ~ 2 log10 or greater reductions of VRE and MRSA
  • ~ 1 log10 reduction of C. difficile spores
  • UVC device 2 yielded significantly greater reductions than 3 and 4
  • No significant difference in efficacy of non-standard devices
  • Device with adjustable arms was as effective as standard

UVC vertical tower devices despite lower UVC intensity

  • Adjustable bulbs were extended horizontally over test surface

Cadnum JL et al. Infect Control Hosp Epidemiol 2019;40:158

slide-25
SLIDE 25

Impact of UVC Decontamination Systems

  • n Healthcare-Associated Infections
  • Multiple other studies have shown that UVC and PX-UV devices can

reduce bacterial contamination of surfaces

  • Systematic review included 13 UV studies
  • When results of studies were pooled, statistically significant reduction
  • C. difficile - pRR, 0.64 VRE - pRR, 0.42
  • No significant reductions in MRSA or Gram-negative incidence rates
  • Health Quality Ontario reviewed 10 studies published before Feb

2017 for evidence of efficacy vs C. difficile

  • 3 studies on UVC [including BETR study], 7 studies on PX-UV
  • Findings were inconsistent or of very low quality (GRADE system)
  • Conclusion: Unable to make firm conclusion regarding efficacy

Marra AR et al. Infect Control Hosp Epidemiol 2018;39:20 Ont Health Technol Assess Ser 2018;18:1

slide-26
SLIDE 26

Impact of UVC Decontamination Systems

  • n Healthcare-Associated Infections
  • Secondary analysis of BETR study
  • Multicenter prospective, cluster-randomized crossover trial of UVC

for terminal disinfection of hospital rooms 9 hospitals, comparing

  • Standard quat disinfectant alone (reference)
  • Standard quat disinfectant + UVC
  • Sodium hypochlorite (bleach) alone
  • Sodium hypochlorite + UVC
  • Outcome measures
  • Hospital-wide incidence of acquisition or infection due to MRSA, VRE or
  • C. difficile
  • Results
  • Significant hospital-wide reduction in acquisition of C. difficile (p = 0.031)

and VRE (p = 0.48)

26

Anderson DJ et al. Lancet Infect Dis 2018;18:845

slide-27
SLIDE 27

Assessing UVC Doses Achieved in Hospital Settings

Boyce JM et al. Infect Control Hosp Epidemiol 2016;37:667-672

  • Current options include:
  • Device with built-in sensors on device
  • Device supplied with separate radiometers
  • Purchase commercially-available radiometers
  • Photochromic (colorimetric) indicator test strips
slide-28
SLIDE 28

Fleming M et al. Am J Infect Control 2018;46:241

Implementation Issues to Consider

slide-29
SLIDE 29

Issues to Address When Considering Mobile Ultraviolet Light Systems

  • Duration of cycle times recommended by manufacturer
  • Evidence of microbiological efficacy published by

independent investigators

  • Cost per device ($40,000 - $125,000)
  • Cost of replacement bulbs/service contracts
  • Availability of digital recording, storage & retrieval of data
  • Ease of use

– Affects the frequency of use; number of rooms disinfected

29

slide-30
SLIDE 30

Issues to Address When Considering Mobile Ultraviolet Light Systems

  • Spencer et al. used human factors engineering to identify factors

affecting device selection

  • Room turn-around time was a deciding factor
  • A pause and reposition capability was considered desirable
  • Ease of maneuverability was a factor
  • Use of a dedicated EVS personnel to operate the device
  • Ability to monitor UV doses delivered and device utilization
  • Forming a multidisciplinary team to develop a business case for

use of UV can facilitate administrative approval

  • Focus group held at APIC meeting identified selection criteria
  • Efficacy
  • Cycle time (room turn-around time)
  • Device cost
  • Ease of use/portability

Spencer M et al. Am J Infect Control 2017;45:288

slide-31
SLIDE 31

Comparison of HPV vs Mobile UV Light System

  • Prospective study involving 15 rooms, each decontaminated once

with HPV and UV-C light processes, at intervals > 2 months

  • Of sites which had (+) ACCs before decontamination

– 93% yielded no growth after HPV treatment – 52% yielded no growth after UV-C light treatment

  • Mean C. difficile log reductions: > 6 logs for HPV vs ~ 2 logs for UVC
  • Mean cycle times: 153 min for HPV vs 73 min for UVC
  • HPV was significantly more effective in rendering surfaces culture-

negative; more effective vs spores

  • UVC was faster and easier to use

Havill NL & Boyce JM ICHE 2012;33:507

31

slide-32
SLIDE 32

Other Technologies for Terminal Room Disinfection

  • Ultrasonic peracetic acid/hydrogen peroxide fogging
  • In 1 published study, the system eliminated MRSA, C. difficile and

VRE from stainless steel disks placed in 7 patient rooms, with > 5 log10 reductions

  • Several hospitals using the system monitored air for hydrogen

peroxide and acetic acid at time of implementation

  • Total setup and operation time was ~ 1 hr
  • Another laboratory based study showed significant reduction of

spores

  • No published data regarding impact on HAI rates

Mana TSC et al. Am J Infect Control 2017;45:327 Wood JP et al. J Hazardous Materials 2013;250:61

slide-33
SLIDE 33

Other Technologies for Terminal Room Disinfection

  • Gaseous ozone has been proposed as a method
  • f room decontamination, but few clinical

studies are available

  • Sharma M Am J Infect Control 200836:559
  • Moat J et al. Can J Microbiol 2009;55:928
  • Alcohol/quaternary ammonium fogging system

was shown to be less effective than bleach

  • Jury LA et al. Am J Infect Control 2010;38:234
  • Chlorine dioxide fogging is promoted for room

decontamination, but few published studies in hospital settings are available

  • Lowe JJ et al. J Occup Environ Hyg 2013;10:533

33

slide-34
SLIDE 34

Self-Disinfecting Surfaces

  • Systematic review of antimicrobial surfaces revealed:
  • 7 studies of copper, 1 of silver, 2 of organosilanes, 1 of metal alloy
  • Copper produced a median of < 1 log10 reduction (range <1 – 2 log10)
  • Two trials reported reduced HAIs in units equipped with copper alloy

surfaces or linen, but were considered to be of low quality

  • Conclusion: further studies are needed to assess impact on HAIs
  • Recent study employed copper-alloy coated surfaces and

copper-containing linens in a new wing of a hospital

  • Reported 83% fewer C. difficile infections, fewer MDRO HAIs
  • However, study had several limitations
  • Other types of self-disinfecting surfaces under investigation
  • Shark skin-like surfaces
  • Titanium dioxide-coated surfaces

Muller MP et al. J Hosp Infect 2016;92:7 Salgado CD et al. Infect Control Hosp Epidemiol 2013;34:479 Sifri CD et al. Am J Infect Control 2016;44:1565 Querido MM et al. Colloids Surf B Biointerfaces 2019;178:8

slide-35
SLIDE 35

Narrow-Spectrum High Intensity (405 nm) Light

  • Narrow-spectrum high intensity

(405 nm) visible light

  • Slow germicidal effect that increases with

extended exposure times

  • Targets porphyrins in bacteria
  • Release of intracellular reactive oxygen

species that have antimicrobial properties

  • Laboratory & clinical studies have

shown reduction of bacteria on surfaces

  • Blue light effective against vegetative

pathogens and C. difficile spores

  • White light not effective vs C. difficile

spores

  • Can be used when patients or

personnel are in room

  • Data on impact on HAIs are needed

Maclean M et al. J Hosp Infect 2014;88:1 Bache SE et al. J Hosp Infect 2018;98:67 Rutala WA et al. Infect Control Hosp Epidemiol 2018;39:1250

slide-36
SLIDE 36

UV-Based Air Decontamination

  • Increased interest in indoor air quality
  • Aerosolization of healthcare pathogens
  • E.g., S. aureus, C. difficile, Acinetobacter baumannii
  • Surface contamination by airborne pathogens
  • Decontamination of indoor air to reduce surface contamination

and healthcare-associated infections

  • Variety of technologies are under investigation
  • Impact on surface contamination, pathogen transmission and HAIs not clear, and

requires further studies

Best EL et al. Clin Infect Dis 2010;50:1450 Smith J et al. J Hosp Infect 2018;100:e123 Wei J et al. Am J Infect Control 2016;44:S102 Sattar SA et al. Am J Infect Control 2016;44:e177 Guimera D et al. Am J Infect Control 2018;46:223 Zargar B et al. Lett Appl Microbiol 2019;68:206 Parvizi J et al. Am J Infect Control 2017;45:1267 Bischoff W et al. Am J Infect Control 2019 (Epub ahead of print)

slide-37
SLIDE 37

Device is installed in HVAC system Shielded ceiling-mounted device

Examples of Air Decontamination Systems

Systems with UVC + Filter

slide-38
SLIDE 38

Summary

  • Achieving and maintaining optimal daily and terminal

disinfection of surfaces are a continuing challenge

  • “No-touch” technologies designed to supplement, but not

replace, manual cleaning/disinfection have the potential to improve the quality of environmental disinfection

  • Despite limitations of published studies, current evidence
  • Demonstrates that novel technologies can reduce environmental

contamination

  • Suggests their use can play a role in reducing HAIs
  • Continued research on the impact of using “no-touch”

technologies on transmission of pathogens and reduction of HAIs is needed

slide-39
SLIDE 39